Clover Health Investments, Corp.: Form 10-Q for the period ended Mar 31, 2020
Filed with the SEC on Jun 4, 2020 and accepted by EDGAR at Jun 4, 2020, 16:50 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Net income | 3 months2020-01-01 to 2020-03-31 | $0 | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-01-01 to 2020-03-31 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Cash and equivalents | At period end2020-03-31 | $63.4k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2020-03-31 | $650.9k | us-gaap:Assets |
| Current liabilities | At period end2020-03-31 | $643.5k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2020-03-31 | $7.4k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-20-069858. Last ingested by Listed: Nov 6, 2026, 19:00 ET. Listed shows no prices and gives no investment advice.